GP5+/6+ SYBR Green methodology for simultaneous screening and quantification of human papillomavirus

Journal of Clinical Virology

Volumn 45, Issue 2, 2009, Pages 90-95

  de Araujo, Melissa Rodrigues ^a,b   De Marco, Laura ^b   Santos, Carlos F ^a   Rubira Bullen, Izabel Regina Fisher ^a   Ronco, Guglielmo ^c   Pennini, Ilenia ^b   Vizzini, Loredana ^b   Merletti, Franco ^b,c   Gillio Tos, Anna ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF TURIN   (Italy)

^c Center for Oncologic Prevention   (Italy)

Author keywords

Human papillomavirus; Real time PCR; Screening; SYBR Green; Viral load

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SYBR GREEN QUANTITATIVE REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; VIRUS TITRATION; WART VIRUS;

ADULT; AGED; DNA PRIMERS; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSITION TEMPERATURE;

EID: 67349191173     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.03.020     Document Type: Article

References (37)

1. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 90. Human papillomaviruses (2007), International Agency for Research on Cancer (IARC), Lyon, France pp. 55-9
2. Porro A.M., Alchorne M.M., Mota G.R., Michalany N., Pignatari A.C., and Souza I.E. Detection and typing of human papillomavirus in cutaneous warts of patients infected with human immunodeficiency virus type I. Br J Dermatol 149 (2003) 1192-1199
3. Muñoz N., Bosch F.X., Castellsangué X., Diaz M., de Sanjose S., Hammouda D., et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111 (2004) 278-285
4. Chan S.Y., Delius H., Halpern A.L., and Bernard H.U. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 69 (1995) 3074-3083
5. Zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1288 (1996) F55-F78
6. Steben M., and Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol 107 (2007) S2-5
7. Lillo F.B., Lodini S., Ferrari D., Stayton C., Taccagni G., Galli L., et al. Determination of human papillomavirus (HPV) load and type in high grade cervical lesions surgically resected from HIV-infected women during follow up of HPV infection. Clin Infect Dis 40 (2005) 451-457
8. Dalstein V., Riethmuller D., Pretet J.L., Le Bail C.K., Sautiere J.L., Carbillet J.P., et al. Persistence and load of high risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 106 (2003) 396-403
9. Hernandez-Hernandez D.M., Ornelas-Bernal L., Guido-Jimenez M., Apresa-Garcia T., Alvarado-Cabrero I., Salcedo-Vargas M., et al. Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women. Gynecol Oncol 90 (2003) 310-317
10. Gravitt P.E., Kovacic M.B., Herrero R., Schiffman M., Bratti C., Hildesheim A., et al. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 121 (2007) 2787-2793
11. Weissenborn S.J., Funke A.M., Hellmich M., Mallmann P., Fuchs P.G., Pfister H.J., et al. Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated. J Clin Microbiol 41 (2003) 2763-2767
12. Sun C.A., Liu J.F., Wu D.M., Nieh S., Yu C.P., and Chu T.Y. Viral load of high risk human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet 76 (2002) 41-47
13. Josefsson A.M., Magnusson P.K., Ylitalo N., Sorensen P., Qwarforth-Tubbin P., Andersen P.K., et al. Viral load of human papillomavirus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355 (2000) 2189-2193
14. Snijders P.J., Hogewoning C.J., Hesselink A.T., Berkhof J., Voorhorst F.J., Bleeker M.C., et al. Determination of viral load thresholds in cervical scarpings to rule out CIN 3 in HPV16, 18, 31, and 33-positive women with normal cytology. Int J Cancer 119 (2006) 1102-1107
15. Broccolo F., and Cocuzza C.E. Automated extraction and quantification of oncogenic HPV genotypes from cervical samples by a real-time PCR-based system. J Virol Methods 148 (2008) 48-57
16. Sotlar K., Diemer D., Dethleffs A., Hack Y., Stubner A., Vollmer N., et al. Detection and typing of HPV by E6 nested multiplex PCR. J Clin Microbiol 42 (2004) 3176-3184
17. Jacobs M.V., De Roda Husman A.M., Van Den Brule A.J.C., Snijders P.J.F., Meijer C.J.L.M., and Walboomers J.M.M. Group-specific differentiation between high and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 33 (1995) 901-905
18. Gillio-Tos A., De Marco L., Ghisetti V., Snijders P.J.F., Segnan N., Ronco G., et al. Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits. J Clin Virol 36 (2006) 126-132
19. Ronco G., Ghisetti V., Segnan N., Snijders P.J., Gillio-Tos A., Meijer C.J., et al. Prevalence of papillomavirus infection in women in Turin, Italy. Eur J Cancer 41 (2005) 297-305
20. Durst M., Croce C.M., Gissmann L., Schwarz E., and Huebner K. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA 84 (1987) 1070-1074
21. Corstjens P., Zuiderwijk M., Brink A., Li S., Feindt H., Niedbala R.S., et al. Use of up-converting phosphor reporters in lateral-flow assays to detect specific nucleic acid sequences: a rapid, sensitive DNA test to identify human papillomavirus type 16 infection. Clin Chem 47 (2001) 1885-1893
22. Biedermann K., Dandachi N., Trattner M., Vogl G., Doppelmayr H., Moré E., et al. Comparison of real-time PCR signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in archival cervical cancer tissue. J Clin Microbiol 42 (2004) 3758-3765
23. Van Duin M., Snijders P.J., Schrijnemakers H.F.J., Voorhorst F.J., Rozendaal L., Nobbehuis A.E., et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer 98 (2002) 590-595
24. Cubie H.A., Seagar A.L., McGoogan E., Whitehead J., Brass A., Arends M.J., et al. Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18. Clin Mol Pathol 54 (2001) 24-29
25. Van den Brule A.J., Pol R., Fransen-Daalmeijer N., Schouls L.M., Meijer C.J., and Snijders P.J. GP5+/6+-PCR followed by reverse line blot analysis enabled rapid and high throughput identification of human papillomavirus genotypes. J Clin Microbiol 40 (2002) 779-787
26. Schimitt M., Dondog B., Waterboer T., and Pawlita M. Homogeneous amplification of genital alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol 46 (2008) 1050-1059
27. Ririe K.M., Rasmussen R.P., and Wittwer C.T. Product differentiation by analysis of DNA melting curves during polymerase chain reaction. Anal Biochem 245 (1997) 154-160
28. Moberg M., Gustavsson I., Wilander E., and Gyllenstein U. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer 92 (2005) 891-894
29. Peitsaro P., Johansson B., and Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 40 (2002) 886-891
30. De Marco L., Gillio-Tos A., Bonello L., Ghisetti V., Ronco G., and Merletti F. Detection of human papillomavirus type 16 integration in pre-neoplastic cervical lesions and confirmation by DIPS-PCR and sequencing. J Clin Virol 38 (2007) 7-13
31. Fleiss J.L. Statistical methods for rates and proportion. 2nd ed. (1981), John Wiley & Sons Inc., New York
32. Lin L.I.K. A concordance correlation coefficient to evaluate reproducibility. Biometrics 45 (1989) 255-268
33. Payan C., Ducancelle A., Aboubaker M.H., Caer J., Tapia M., Chauvin A., et al. Human Papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real time PCR systems. J Clin Microbiol 45 (2007) 897-901
34. Kulmala S.M., Syrjänen S.M., Gyllensten U.B., Shabalova I.P., Petrovichev N., Tosi P., et al. Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 59 (2006) 513-517
35. Szuhai K., Sandhaus E., Kolkman-Uljee S.M., Lemaitre M., Truffert J.C., Dirks R.W., et al. A novel strategy for human papillomavirus detection and genotyping with SYBRGreen and molecular beacon polymerase chain reaction. Am J Pathol 159 (2001) 1651-1660
36. Witweer C.T., Ririe K.M., Andrew R.V., David D.A., Gundry R.A., and Ballis U.J. The lightcycler™: a microvolume multisample fluorimeter with rapid temperature control. BioTechniques 22 (1997) 176-181
37. Strauss S., Jordens J.Z., Desselberger U., and Gray J.J. Single-tube real time nested polymerase chain reaction for detecting human papillomavirus DNA. Diagn Mol Pathol 9 (2000) 151-157